Tocqueville Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Tocqueville Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,500	Closed	-$238K	–	640
2022 Q3	$238K	Sell	3,500 -10,250	-75%	-$565K	﹤0.01%	547
2022 Q2	$439K	Hold	13,750	–	–	0.01%	516
2022 Q1	$476K	Buy	13,750 +3,000	+28%	+$89.7K	0.01%	528
2021 Q4	$315K	Buy	+10,750	New	+$333K	﹤0.01%	635
2019 Q1	–	Sell	-8,850	Closed	-$363K	–	802
2018 Q4	$363K	Sell	8,850 -1,550	-15%	-$58.1K	0.01%	602
2018 Q3	$395K	Buy	10,400 +1,450	+16%	+$64.2K	0.01%	654
2018 Q2	$405K	Buy	8,950 +600	+7%	+$27.3K	0.01%	642
2018 Q1	$403K	Buy	+8,350	New	+$466K	0.01%	654

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tocqueville Asset Management's GBT Position: Q4 2022 in Review

Tocqueville Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,500 shares — an estimated $238K sold.

Tocqueville Asset Management first reported a position in GBT in Q1 2018 and held it in 8 quarters. The position peaked at $476K in Q1 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Tocqueville Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Tocqueville Asset Management sold 3,500 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $238K.
Tocqueville Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 8 quarters.
Tocqueville Asset Management's Global Blood Therapeutics, Inc. position peaked at $476K in Q1 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Tocqueville Asset Management's 13F filing for Q4 2022, filed 9 Feb 2023.